...
| Dataset wrap |
|---|
|
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | ETCD | ELEMENT | TESTRL | TEENRL | TEDUR |
|---|
| 1 | TDM2 | TE | SCRN | Screen | Start of Pretreatment | 1 week after start of Element | P7D | | 2 | TDM2 | TE | TRT01 | Vehicle Control | First day of dosing with vehicle control | Date of necropsy: 28 to 30 days after start of Element |
| | 3 | TDM2 | TE | TRT02 | 100 mg/kg Drug A, once daily | First day of dosing with 100 mg/kg Drug A | Date of necropsy: 28 to 30 days after start of Element |
| | 4 | TDM2 | TE | TRT03 | 500 mg/kg Drug A, once daily | First day of dosing with 500 mg/kg Drug A | Date of necropsy: 28 to 30 days after start of Element |
|
|
|
Trial Arms
There are three 3 trial arms in this study. The fact that some subjects are being selected for blood sampling is an experimental factor that is separate from the treatment being received; this is described in the TS example.
...